Adjuvant therapy in colon cancer--what, when and how?

Annals of Oncology : Official Journal of the European Society for Medical Oncology
I Chau, D Cunningham

Abstract

Bolus fluorouracil and leucovorin has been accepted as the standard adjuvant therapy in stage III colon cancer for many years. New drugs such as irinotecan, oxaliplatin and oral fluoropyrimidines have all completed phase III randomised evaluation in colon cancer. Several of these studies have been reported in the last 24 months. Oxaliplatin-based chemotherapy is now emerging as the new standard of care in adjuvant treatment of stage III colon cancer. The advent of monoclonal antibodies such as cetuximab and bevacizumab has further broadened the treatment horizon for colorectal cancer and they are the focus of the on-going randomised studies in adjuvant therapy of colon cancer. In stage II colon cancer, adjuvant treatment remains controversial and is not routinely recommended in all medically fit patients by the current American Society of Clinical Oncology guidelines, except several subsets including poorly differentiated histology, T4 lesions, bowel perforation presentation and inadequately sampled lymph nodes (<13). This review focuses on the relative merits of these agents, their safety, duration of treatment, timing of commencing treatment after surgery and the role of adjuvant therapy in stage II colon cancer, thereby assi...Continue Reading

Citations

Nov 30, 2007·International Journal of Colorectal Disease·Anne Y LinMartin R Weiser
Jan 4, 2008·Diseases of the Colon and Rectum·Karl Y BilimoriaClifford Y Ko
Aug 8, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Cristina GrávalosAlfredo Carrato
Apr 9, 2011·Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·Celestia DavisMaria Marjorette O Peña
Jun 24, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Stanley R Hamilton
Aug 23, 2012·Nature Reviews. Clinical Oncology·Whay Kuang ChiaHan Chong Toh
Aug 7, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A A ArgyriouH P Kalofonos
Aug 13, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F N van ErningV E P P Lemmens
May 16, 2009·Current Opinion in Oncology·Alain Hendlisz, Vassilis Golfinopoulos
Jan 5, 2011·BMC Cancer·Geoffrey A PorterEva Grunfeld
May 21, 2011·BMC Medical Genomics·Xiaohong LiSusmita Datta
Oct 5, 2011·Annals of Surgical Oncology·Geoffrey A PorterEva Grunfeld
Mar 28, 2009·International Journal of Molecular Sciences·Min-Tze Liong
Jan 6, 2012·International Journal of Oncology·Hisanori MikiAiro Tsubura
Aug 6, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Liping MaXiaoxiong Zeng
Dec 7, 2007·Internal and Emergency Medicine·M Ponz de LeonP Benatti
Dec 6, 2008·The Nurse Practitioner·Darlene P Peters
May 24, 2012·Techniques in Coloproctology·S MemonA C Lynch
Mar 2, 2010·International Journal of Food Sciences and Nutrition·Manoj KumarHariom Yadav
Apr 16, 2011·Scandinavian Journal of Gastroenterology·Luca Reggiani BonettiMaurizio Ponz de Leon
Oct 31, 2012·Pharmacology & Therapeutics·John M Furgason, El Mustapha Bahassi
Jul 21, 2010·Clinical Colorectal Cancer·Soley BayraktarCaio M Rocha-Lima
Mar 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhe-Yi HuYuan-Sheng Zhao
Feb 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gaetan Des GuetzBernard Uzzan
Oct 20, 2009·European Journal of Pharmacology·V Raja Solomon, Hoyun Lee
Aug 21, 2009·Gastroentérologie Clinique Et Biologique·J-F Fléjou, P Cervera
Oct 2, 2015·EBioMedicine·Daniela KandiolerUNKNOWN p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG)
Jan 29, 2008·Journal of the American College of Surgeons·Karl Y BilimoriaClifford Y Ko
Jul 3, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Per E Lønning, Jürgen Geisler
Mar 27, 2007·European Journal of Pharmacology·Ricardo P GarayCarlo Chiavaroli
Sep 12, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A C R K BosV E P P Lemmens
Jun 26, 2010·Journal of Surgical Oncology·A RajputD Schrag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Al B BensonD G Haller
Biochimica Et Biophysica Acta
Debby M E I HellebrekersManon van Engeland
American Journal of Surgery
Sergio HuertaEdward H Livingston
© 2021 Meta ULC. All rights reserved